EUVIMEDEUVIMED entdecken
Crossref

Aspect ratio-dependent dual-regulation of the tumor immune microenvironment against osteosarcoma by hydroxyapatite nanoparticles

Hongfeng Wu, Ruiqi Wang, Shu Li, Siyu Chen, Shuo Liu, Xiangfeng Li, Xiao Yang, Qin Zeng, Yong Zhou, Xiangdong Zhu, Kai Zhang, Chongqi Tu und 1 weitere

Acta Biomaterialia · 2023

DOI: 10.1016/j.actbio.2023.08.046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2023. Verfasst von Hongfeng Wu und 12 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China; College of Biomedical Engineering, Sichuan Universi…. Hauptthemen laut MEDLINE: HMGB1 Protein, Osteosarcoma, Nanoparticles, Bone Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Key Research and Development Program of China Stem Cell and Translational Research, Sichuan Province Science and Technology Support Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accumulating studies demonstrated that hydroxyapatite nanoparticles (HANPs) showed a selective anti-tumor effect, making them a good candidate for osteosarcoma (OS) treatment. However, the capacity of HANPs with different aspect ratios to regulate tumor immune microenvironment (TIM) was scarcely reported before. To explore it, the three HANPs with aspect ratios from 1.86 to 6.25 were prepared by wet chemical method. After a 24 or 72 h-exposure of OS UMR106 cells or macrophages to the nanoparticles, the tumor cells exhibited immunogenic cell death (ICD) indicated by the increased production of calreticulin (CRT), adenosine triphosphate (ATP) and high mobility group box 1 (HMGB1), and macrophages were activated with the release of pro-inflammatory cytokines. Next, the beneficial crosstalk between tumor cells and macrophages generated in the presence of HANPs for improved anti-tumor immunity activation. In the OS-bearing cognate rat model, HANPs inhibited OS growth, which was positively correlated with CRT and HMGB1 expression, and macrophage polarization in the tumor tissues. Additionally, HANPs promoted CD8+ T cell infiltration into the tumor and systemic dendritic cell maturation. Particularly, HANPs bearing the highest aspect ratio exhibited the strongest immunomodulatory and anti-tumor function. This study suggested the potential of HANPs to be a safe and effective drug-free nanomaterial to control the TIM for OS therapy. STATEMENT OF SIGNIFICANCE: Emerging studies demonstrated that hydroxyapatite nanoparticles (HANPs) inhibited tumor cell proliferation and tumor growth. However, the underlying anti-tumor mechanism still remains unclear, and the capacity of HANPs without any other additive to regulate tumor immune microenvironment (TIM) was scarcely reported before. Herein, we demonstrated that HANPs, in an aspect ratio-dependent manner, showed the potential to delay the growth of osteosarcoma (OS) and to regulate TIM by promoting the invasion of CD8+ T cells and F4/80+ macrophages, and inducing immunogenic cell death (ICD) in tumors. This work revealed the new molecular mechanism for HANPs against OS, and suggested HANPs might be a novel ICD inducer for OS treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HMGB1 ProteinOsteosarcomaNanoparticlesBone NeoplasmsRatsAnimalsDurapatiteCD8-Positive T-LymphocytesCell Line, TumorTumor Microenvironment

Stichwörter der Autor:innen

Aspect ratioHydroxyapatite nanoparticlesImmunogenic cell deathMacrophage polarizationTumor immune microenvironment

Substanzen

DurapatiteHMGB1 Protein

Autor:innen und Institutionen

  • National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China; College of Biomedical Engineering, Sichuan University, Chengdu 610064, China; Medical School, Kunming University of Scien…
  • Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan University, Chengdu 610041, China.
  • National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China; NMPA Key Laboratory for Quality Research and Control of Tissue Regenerative Biomaterials & Institute of Regulatory Scienc…
  • National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China; College of Biomedical Engineering, Sichuan University, Chengdu 610064, China.
  • National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China; Provincial Engineering Research Center for Biomaterials Genome of Sichuan & Research Center for Materials Genome Engineer…
  • Department of Orthopedics, West China Hospital, Sichuan University, Chengdu 610041, China.

Förderung

  • National Key Research and Development Program of China Stem Cell and Translational Research
  • Sichuan Province Science and Technology Support Program
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Wu, H., Wang, R., Li, S., Chen, S., Liu, S., Li, X., Yang, X., Zeng, Q., Zhou, Y., Zhu, X., Zhang, K., Tu, C., & Zhang, X. (2023). Aspect ratio-dependent dual-regulation of the tumor immune microenvironment against osteosarcoma by hydroxyapatite nanoparticles. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2023.08.046

Vancouver

Wu H, Wang R, Li S, Chen S, Liu S, Li X, et al. Aspect ratio-dependent dual-regulation of the tumor immune microenvironment against osteosarcoma by hydroxyapatite nanoparticles. Acta Biomaterialia. 2023. doi:10.1016/j.actbio.2023.08.046

BibTeX
@article{Wu2023,
  author = {Wu, Hongfeng and Wang, Ruiqi and Li, Shu and Chen, Siyu and Liu, Shuo and Li, Xiangfeng and Yang, Xiao and Zeng, Qin and Zhou, Yong and Zhu, Xiangdong and Zhang, Kai and Tu, Chongqi and Zhang, Xingdong},
  title = {Aspect ratio-dependent dual-regulation of the tumor immune microenvironment against osteosarcoma by hydroxyapatite nanoparticles},
  journal = {Acta Biomaterialia},
  year = {2023},
  doi = {10.1016/j.actbio.2023.08.046}
}
Kostenlos starten →